BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37234172)

  • 1. MRGPRX2 signaling involves the Lysyl-tRNA synthetase and MITF pathway.
    Guo Y; Ollé L; Proaño-Pérez E; Aparicio C; Guerrero M; Muñoz-Cano R; Martín M
    Front Immunol; 2023; 14():1154108. PubMed ID: 37234172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The function of lysyl-tRNA synthetase and Ap4A as signaling regulators of MITF activity in FcepsilonRI-activated mast cells.
    Lee YN; Nechushtan H; Figov N; Razin E
    Immunity; 2004 Feb; 20(2):145-51. PubMed ID: 14975237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LysRS serves as a key signaling molecule in the immune response by regulating gene expression.
    Yannay-Cohen N; Carmi-Levy I; Kay G; Yang CM; Han JM; Kemeny DM; Kim S; Nechushtan H; Razin E
    Mol Cell; 2009 Jun; 34(5):603-11. PubMed ID: 19524539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Mast Cell Line HMC1 Expresses Functional Mas-Related G-Protein Coupled Receptor 2.
    Hermans MAW; van Stigt AC; van de Meerendonk S; Schrijver B; van Daele PLA; van Hagen PM; van Splunter M; Dik WA
    Front Immunol; 2021; 12():625284. PubMed ID: 33790895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural switch of lysyl-tRNA synthetase between translation and transcription.
    Ofir-Birin Y; Fang P; Bennett SP; Zhang HM; Wang J; Rachmin I; Shapiro R; Song J; Dagan A; Pozo J; Kim S; Marshall AG; Schimmel P; Yang XL; Nechushtan H; Razin E; Guo M
    Mol Cell; 2013 Jan; 49(1):30-42. PubMed ID: 23159739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRGPRX2, drug pseudoallergies, inflammatory diseases, mechanisms and distinguishing MRGPRX2- and IgE/FcεRI-mediated events.
    Baldo BA
    Br J Clin Pharmacol; 2023 Nov; 89(11):3232-3246. PubMed ID: 37430437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones.
    Elst J; Maurer M; Sabato V; Faber MA; Bridts CH; Mertens C; Van Houdt M; Van Gasse AL; van der Poorten MM; De Puysseleyr LP; Hagendorens MM; Van Tendeloo VF; Lion E; Campillo-Davo D; Ebo DG
    Front Immunol; 2021; 12():668962. PubMed ID: 34385999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic Stromal Lymphopoietin Promotes MRGPRX2-Triggered Degranulation of Skin Mast Cells in a STAT5-Dependent Manner with Further Support from JNK.
    Babina M; Wang Z; Franke K; Zuberbier T
    Cells; 2021 Jan; 10(1):. PubMed ID: 33429916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia.
    Navinés-Ferrer A; Serrano-Candelas E; Lafuente A; Muñoz-Cano R; Martín M; Gastaminza G
    Sci Rep; 2018 Aug; 8(1):11628. PubMed ID: 30072729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeic acid phenethyl ester inhibits pseudo-allergic reactions via inhibition of MRGPRX2/MrgprB2-dependent mast cell degranulation.
    Adhikari N; Shim WS
    Arch Pharm Res; 2022 Sep; 45(9):644-657. PubMed ID: 36183260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-33 and MRGPRX2-Triggered Activation of Human Skin Mast Cells-Elimination of Receptor Expression on Chronic Exposure, but Reinforced Degranulation on Acute Priming.
    Wang Z; Guhl S; Franke K; Artuc M; Zuberbier T; Babina M
    Cells; 2019 Apr; 8(4):. PubMed ID: 30979016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRGPRX2-Mediated Degranulation of Human Skin Mast Cells Requires the Operation of G
    Wang Z; Franke K; Bal G; Li Z; Zuberbier T; Babina M
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonconventional involvement of LysRS in the molecular mechanism of USF2 transcriptional activity in FcepsilonRI-activated mast cells.
    Lee YN; Razin E
    Mol Cell Biol; 2005 Oct; 25(20):8904-12. PubMed ID: 16199869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MITF Downregulation Induces Death in Human Mast Cell Leukemia Cells and Impairs IgE-Dependent Degranulation.
    Proaño-Pérez E; Ollé L; Guo Y; Aparicio C; Guerrero M; Muñoz-Cano R; Martin M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin inhibits Mrgprx2-induced pseudo-allergic reaction via PLCγ-IP3R related Ca
    Ding Y; Che D; Li C; Cao J; Wang J; Ma P; Zhao T; An H; Zhang T
    Int Immunopharmacol; 2019 Jan; 66():185-197. PubMed ID: 30471617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thimerosal induces skin pseudo-allergic reaction via Mas-related G-protein coupled receptor B2.
    Peng B; Che D; Hao Y; Zheng Y; Liu R; Qian Y; Cao J; Wang J; Zhang Y; He L; Geng S
    J Dermatol Sci; 2019 Sep; 95(3):99-106. PubMed ID: 31558225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: Modulation by sugammadex.
    Fernandopulle NA; Zhang SS; Soeding PF; Mackay GA
    Clin Exp Allergy; 2021 May; 51(5):685-695. PubMed ID: 33275825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unlocking the Non-IgE-Mediated Pseudo-Allergic Reaction Puzzle with Mas-Related G-Protein Coupled Receptor Member X2 (MRGPRX2).
    Kumar M; Duraisamy K; Chow BK
    Cells; 2021 Apr; 10(5):. PubMed ID: 33925682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imiquimod-related dermatitis is mainly mediated by mast cell degranulation via Mas-related G-protein coupled receptor B2.
    Hao Y; Peng B; Che D; Zheng Y; Kong S; Liu R; Shi J; Han H; Wang J; Cao J; Zhang Y; Gao J; He L; Geng S
    Int Immunopharmacol; 2020 Apr; 81():106258. PubMed ID: 32044660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-trans-retinoic acid activated mast cells via Mas-related G-protein-coupled receptor-X2 in retinoid dermatitis.
    Zheng Y; Che D; Peng B; Hao Y; Zhang X; He L; Geng S
    Contact Dermatitis; 2019 Sep; 81(3):184-193. PubMed ID: 31006867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.